Table 4.
Control (n=84) | DMED group (n=84) | t | P | |
---|---|---|---|---|
sCr (mol/L) | ||||
T0 | 79.12±9.75 | 78.18±8.84 | 0.655 | 0.514 |
T1 | 77.15±10.02 | 79.28±11.46 | 1.282 | 0.202 |
T2 | 84.26±15.54 | 83.48±17.26 | 0.308 | 0.759 |
T3 | 93.46±17.28 | 85.43±16.24 | 3.103 | 0.002 |
T4 | 106.28±14.53 | 87.49±14.61 | 4.799 | 0.000 |
NF-κB | ||||
T0 | 9.68±1.12 | 9.25±2.36 | 1.509 | 0.133 |
T1 | 14.25±2.86 | 13.69±3.23 | 1.189 | 0.235 |
T2 | 20.18±3.83 | 16.47±6.54 | 4.486 | 0.000 |
T3 | 34.28±4.54 | 20.67±5.44 | 17.604 | 0.000 |
T4 | 54.19±5.75 | 24.08±7.72 | 28.668 | 0.000 |
Caspase-3 | ||||
T0 | 2.35±0.56 | 2.42±0.76 | 0.679 | 0.498 |
T1 | 2.41±0.12 | 2.39±0.23 | 0.707 | 0.481 |
T2 | 2.92±0.25 | 2.87±0.35 | 1.065 | 0.288 |
T3 | 3.02±0.81 | 2.98±0.63 | 0.357 | 0.721 |
T4 | 3.11±0.43 | 2.97±0.85 | 1.347 | 0.179 |
IL-1β (ng/mL) | ||||
T0 | 62.49±10.03 | 59.63±12.85 | 1.608 | 0.109 |
T1 | 70.15±12.54 | 72.59±13.69 | 1.204 | 0.230 |
T2 | 82.55±14.49 | 83.49±13.82 | 0.430 | 0.667 |
T3 | 100.06±14.48 | 86.49±11.33 | 6.764 | 0.000 |
T4 | 123.59±16.26 | 90.48±16.69 | 13.023 | 0.000 |
TNF-α (ng/mL) | ||||
T0 | 87.54±12.26 | 90.36±17.82 | 1.195 | 0.233 |
T1 | 103.25±16.66 | 108.53±24.49 | 1.634 | 0.104 |
T2 | 145.62±20.15 | 151.87±29.54 | 1.602 | 0.111 |
T3 | 263.49±26.58 | 195.49±20.15 | 18.685 | 0.000 |
T4 | 350.48±27.69 | 261.45±24.44 | 22.093 | 0.000 |
TLR3 | ||||
T0 | 8.56±1.21 | 8.34±1.43 | 1.076 | 0.283 |
T1 | 13.18±2.35 | 12.96±2.26 | 0.618 | 0.537 |
T2 | 19.32±4.51 | 11.46±5.68 | 9.933 | 0.000 |
T3 | 22.37±4.57 | 10.67±5.57 | 14.883 | 0.000 |
T4 | 28.38±6.52 | 9.09±6.76 | 18.824 | 0.000 |
Notes: T0: before operation; T1: 30 min after anesthesia induction; T2: 24 h after operation; T3: 48 h after operation; T4: 72 h after operation; sCr: serum creatinine; IL: interleukin; TLR: toll-like receptor; TNF: tumor necrosis factor; DMED: dexmedetomidine; NF-κB: nuclear factor kappa B.